Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Titov

Showing results (31-40 of 551) with videos related to

Pageof 56
Sort By:
Klinicheskaia Laboratornaia Diagnostika|June 11, 1998
[Clinical chemistry of atherosclerosis]V N Titov
Laboratornoe Delo|January 1, 1991
[Current problems of personnel policy in clinical biochemistry]V N Titov
Laboratornoe Delo|January 1, 1990
[The optimal choice of multichannel analytical systems in clinical biochemistry]V N Titov
Klinicheskaia Laboratornaia Diagnostika|August 2, 2007
[Angiotensin II activation of utilization of biological debris in the arterial intima via endogenous inflammation]V N Titov
Klinicheskaia Meditsina|May 19, 2015
[The basis principles of primary prevention of atherosclerosis]V N Titov
Klinicheskaia Laboratornaia Diagnostika|April 3, 2004
[Functional properties of low density lipoprotein receptor family. Disturbance of cellular uptake of saturated fatty acids mediated by receptors (literature review)]V N Titov
Klinicheskaia Laboratornaia Diagnostika|July 3, 2004
[Exogenic and endogenic pathologic factors (pathogens) as inflammation inducers]V N Titov
Klinicheskaia Laboratornaia Diagnostika|October 16, 2015
[THE BECOMING IN PHYLOGENESIS OF TRANSFER IN INTERCELLULAR MEDIUM AND ACTIVE ABSORPTION OF POLYENOIC FATTY ACIDS BY CELLS SEQUENTIALLY OF HIGH DENSITY LIPOPROTEINS, LOW DENSITY LIPOPROTEINS AND HIGH DENSITY APOE-LIPOPROTEINS]V N Titov
Voprosy Pitaniia|July 7, 1999
[The biological basis for the use of polyunsaturated fatty acids of the omega-3 family in the prevention of atherosclerosis]V N Titov
Klinicheskaia Laboratornaia Diagnostika|September 1, 1995
[Blood sodium]V N Titov
Pageof 56

Showing results (31-40 of 551) with videos related to

Sort By:
Pageof 56
Klinicheskaia Laboratornaia Diagnostika|June 11, 1998
[Clinical chemistry of atherosclerosis]V N Titov
Laboratornoe Delo|January 1, 1991
[Current problems of personnel policy in clinical biochemistry]V N Titov
Laboratornoe Delo|January 1, 1990
[The optimal choice of multichannel analytical systems in clinical biochemistry]V N Titov
Klinicheskaia Laboratornaia Diagnostika|August 2, 2007
[Angiotensin II activation of utilization of biological debris in the arterial intima via endogenous inflammation]V N Titov
Klinicheskaia Meditsina|May 19, 2015
[The basis principles of primary prevention of atherosclerosis]V N Titov
Klinicheskaia Laboratornaia Diagnostika|April 3, 2004
[Functional properties of low density lipoprotein receptor family. Disturbance of cellular uptake of saturated fatty acids mediated by receptors (literature review)]V N Titov
Klinicheskaia Laboratornaia Diagnostika|July 3, 2004
[Exogenic and endogenic pathologic factors (pathogens) as inflammation inducers]V N Titov
Klinicheskaia Laboratornaia Diagnostika|October 16, 2015
[THE BECOMING IN PHYLOGENESIS OF TRANSFER IN INTERCELLULAR MEDIUM AND ACTIVE ABSORPTION OF POLYENOIC FATTY ACIDS BY CELLS SEQUENTIALLY OF HIGH DENSITY LIPOPROTEINS, LOW DENSITY LIPOPROTEINS AND HIGH DENSITY APOE-LIPOPROTEINS]V N Titov
Voprosy Pitaniia|July 7, 1999
[The biological basis for the use of polyunsaturated fatty acids of the omega-3 family in the prevention of atherosclerosis]V N Titov
Klinicheskaia Laboratornaia Diagnostika|September 1, 1995
[Blood sodium]V N Titov
Pageof 56